Wealth Alliance Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $564K | Sell |
1,125
-100
| -8% | -$48K | 0.08% | 112 |
|
|
2026
Q1 | $602K | Buy |
1,225
+103
| +9% | +$55.9K | 0.1% | 108 |
|
|
2025
Q4 | $650K | Hold |
1,122
| – | – | 0.11% | 104 |
|
|
2025
Q3 | $544K | Hold |
1,122
| – | – | 0.1% | 106 |
|
|
2025
Q2 | $455K | Sell |
1,122
-793
| -41% | -$332K | 0.09% | 118 |
|
|
2025
Q1 | $953K | Buy |
1,915
+813
| +74% | +$440K | 0.2% | 76 |
|
|
2024
Q4 | $573K | Sell |
1,102
-39
| -3% | -$21.4K | 0.12% | 97 |
|
|
2024
Q3 | $706K | Hold |
1,141
| – | – | 0.15% | 92 |
|
|
2024
Q2 | $631K | Sell |
1,141
-46
| -4% | -$26.4K | 0.14% | 91 |
|
|
2024
Q1 | $690K | Sell |
1,187
-8
| -0.7% | -$4.49K | 0.16% | 84 |
|
|
2023
Q4 | $634K | Hold |
1,195
| – | – | 0.17% | 81 |
|
|
2023
Q3 | $605K | Sell |
1,195
-32
| -3% | -$17.1K | 0.18% | 77 |
|
|
2023
Q2 | $640K | Buy |
1,227
+69
| +6% | +$37.2K | 0.23% | 70 |
|
|
2023
Q1 | $667K | Hold |
1,158
| – | – | 0.25% | 66 |
|
|
2022
Q4 | $638K | Buy |
1,158
+96
| +9% | +$50.9K | 0.24% | 65 |
|
|
2022
Q3 | $539K | Hold |
1,062
| – | – | 0.24% | 68 |
|
|
2022
Q2 | $577K | Hold |
1,062
| – | – | 0.27% | 63 |
|
|
2022
Q1 | $627K | Sell |
1,062
-631
| -37% | -$362K | 0.27% | 64 |
|
|
2021
Q4 | $1.13M | Buy |
1,693
+149
| +10% | +$93K | 0.49% | 35 |
|
|
2021
Q3 | $882K | Buy |
1,544
+8
| +0.5% | +$4.39K | 0.43% | 43 |
|
|
2021
Q2 | $775K | Buy |
1,536
+20
| +1% | +$9.44K | 0.38% | 51 |
|
|
2021
Q1 | $692K | Buy |
1,516
+447
| +42% | +$213K | 0.35% | 54 |
|
|
2020
Q4 | $498K | Sell |
1,069
-4
| -0.4% | -$1.88K | 0.27% | 61 |
|
|
2020
Q3 | $474K | Sell |
1,073
-3
| -0.3% | -$1.24K | 0.28% | 57 |
|
|
2020
Q2 | $390K | Hold |
1,076
| – | – | 0.24% | 65 |
|
|
2020
Q1 | $305K | Sell |
1,076
-12
| -1% | -$3.78K | 0.24% | 72 |
|
|
2019
Q4 | $353K | Hold |
1,088
| – | – | 0.2% | 79 |
|
|
2019
Q3 | $309K | Sell |
1,088
-8
| -0.7% | -$2.29K | 0.19% | 80 |
|
|
2019
Q2 | $317K | Sell |
1,096
-4
| -0.4% | -$1.1K | 0.2% | 81 |
|
|
2019
Q1 | $299K | Buy |
1,100
+56
| +5% | +$13.9K | 0.19% | 85 |
|
|
2018
Q4 | $234K | Sell |
1,044
-400
| -28% | -$93.8K | 0.18% | 96 |
|
|
2018
Q3 | $352K | Sell |
1,444
-3
| -0.2% | -$690 | 0.18% | 89 |
|
|
2018
Q2 | $300K | Buy |
1,447
+15
| +1% | +$3.18K | 0.16% | 91 |
|
|
2018
Q1 | $296K | Buy |
+1,432
| New | +$301K | 0.17% | 82 |
|
Other funds holding TMO
Wealth Alliance Advisory Group's TMO Position: Q2 2026 in Review
Wealth Alliance Advisory Group reduced its Thermo Fisher Scientific (TMO) stake by 8.2% in Q2 2026, selling an estimated $48K and leaving 1,125 shares worth $564K. The position accounts for 0.08% of the portfolio, ranked #112.
Wealth Alliance Advisory Group first reported a position in TMO in Q1 2018 and has held it in 34 quarters since. The position peaked at $1.13M in Q4 2021. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Wealth Alliance Advisory Group held 1,125 shares of Thermo Fisher Scientific worth $564K as of Q2 2026.
- Wealth Alliance Advisory Group sold 100 Thermo Fisher Scientific shares in Q2 2026, an estimated $48K.
- Thermo Fisher Scientific made up 0.08% of Wealth Alliance Advisory Group's portfolio in Q2 2026, its #112 holding.
- Wealth Alliance Advisory Group first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 34 quarters since.
- Wealth Alliance Advisory Group's Thermo Fisher Scientific position peaked at $1.13M in Q4 2021.
- 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Wealth Alliance Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.